Patent · US Expired

Influenza vaccine composition

US7316813B2 · kind B2 · utility

18Cited by

4References

16Claims

0Family size

Assignee

Saechsisches Serumwerk Dresden Branch of SmithKline Beecham Pharma GmbH & Co KG · DE

Inventor

Uwe Eichhorn · Großerkmannsdorf, DE

Key dates

Filing date	May 29, 2002
Grant date	Jan 8, 2008
Priority date	—
Expiry date	May 29, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An inactivated influenza virus preparation is described which comprises a haemagglutinin antigen stabilized in the absence of thiomersal, or at low levels of thiomersal, wherein the haemagglutinin is detectable by a SRD assay. The influenza virus preparation may comprise a micelle modifying excipient, for example α-tocopherol or a derivative thereof in a sufficient amount to stabilize the haemagglutinin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.